Evidence map›Paper›PMID 26984941›Full record

ArticleHuman molecular genetics2016

The Werner syndrome RECQ helicase targets G4 DNA in human cells to modulate transcription.

Weiliang Tang, Ana I Robles, Richard P Beyer, Lucas T Gray, Giang H Nguyen, Junko Oshima, Nancy Maizels, Curtis C Harris, Raymond J Monnat

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Weiliang TangDepartment of Pathology.
Ana I RoblesLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA and.
Richard P BeyerCenter for Ecogenetics and Environmental Health.
Lucas T GrayDepartment of Immunology.
Giang H NguyenLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA and.
Junko OshimaDepartment of Pathology, Department of Medicine, Chiba University, Chiba, Japan.
Nancy MaizelsDepartment of Pathology, Department of Immunology, Department of Biochemistry.
Curtis C HarrisLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA and.
Raymond J MonnatDepartment of Pathology, Department of Genome Sciences, University of Washington, Seattle, WA, USA, monnat@u.washington.edu.
National Cancer Institute · USChiba University · JPNational Institutes of Health · USUniversity of Washington · US

Funding

Tumor mutation signaturesP01CA077852 · NCI · UNIVERSITY OF WASHINGTON · PI SIDOROVA, JULIA · 1999 to 2019
$26.0M
p53, Aging, and CancerZIABC011496 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2025
$21.1M
International Registry of Werner SyndromeR01CA210916 · NCI · UNIVERSITY OF WASHINGTON · PI JUNKO OSHIMA · 2016 to 2026
$3.8M
DYNAMICS AND FUNCTION OF G4 DNAR01GM065988 · NIGMS · UNIVERSITY OF WASHINGTON · PI MAIZELS, NANCY · 2002 to 2007
$1.4M
International Registry of Werner SyndromeR24AG042328 · NIA · UNIVERSITY OF WASHINGTON · PI MARTIN, GEORGE M., OSHIMA, JUNKO · 2012 to 2015
$743k
NCI NIH HHS P01 CA077852NCI NIH HHS R01 CA210916NIA NIH HHS R24 AG042328NIGMS NIH HHS R01 GM065988
6 · The paper itself

Abstract

The Werner syndrome (WS) is a prototypic adult Mendelian progeroid syndrome in which signs of premature aging are associated with genomic instability and an elevated risk of cancer. The WRN RECQ helicase protein binds and unwinds G-quadruplex (G4) DNA substrates in vitro, and we identified significant enrichment in G4 sequence motifs at the transcription start site and 5' ends of first introns (false discovery rate < 0.001) of genes down-regulated in WS patient fibroblasts. This finding provides strong evidence that WRN binds G4 DNA structures at many chromosomal sites to modulate gene expression. WRN appears to bind a distinct subpopulation of G4 motifs in human cells, when compared with the related Bloom syndrome RECQ helicase protein. Functional annotation of the genes and miRNAs altered in WS provided new insight into WS disease pathogenesis. WS patient fibroblasts displayed altered expression of multiple, mechanistically distinct, senescence-associated gene expression programs, with altered expression of disease-associated miRNAs, and dysregulation of canonical pathways that regulate cell signaling, genome stability and tumorigenesis. WS fibroblasts also displayed a highly statistically significant and distinct gene expression signature, with coordinate overexpression of nearly all of the cytoplasmic tRNA synthetases and associated ARS-interacting multifunctional protein genes. The 'non-canonical' functions of many of these upregulated tRNA charging proteins may together promote WS disease pathogenesis. Our results identify the human WRN RECQ protein as a G4 helicase that modulates gene expression in G4-dependent fashion at many chromosomal sites and provide several new and unexpected mechanistic insights into WS disease pathogenesis.

Indexed as

CarcinogenesisDNA-Binding ProteinsFibroblastsGene Expression RegulationGenome, HumanGenomic InstabilityG-QuadruplexesHumansMicroRNAsNeoplasmsNucleotide MotifsRecQ HelicasesWerner SyndromeDNA-Binding ProteinsMicroRNAsRecQ Helicases

Identifiers

PMID26984941
PMCPMC5062591
OpenAlexW2307754412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.